1/29/2016. Maryland Pharmacists Association Mid-Year Meeting Legislative Update

Transcription

1 Maryland Pharmacists Association Mid-Year Meeting Legislative Update G.S. Proctor & Associates Steve Proctor & Ashley Heffernan We are a full service lobbying and consulting firm in its 20 th year of business. Our team has over 50 years of combined experience. The members of our team come from various backgrounds providing a full range of knowledge to best serve our clients. GS Proctor & Associations has three locations with offices in Annapolis, Prince George s County, and Washington, DC. We are happy to be advocating on behalf of MPhA and its members before the Maryland General Assembly in

2 General Assembly Information Maryland Legislature Demographics Senate The Senate is comprised of 47 members, each representing a different district in the State. 33 Democrats, 14 Republicans 34 Males, 13 Females 37 Caucasians, 9 African-Americans, 1 Asian 23 are native Marylanders Maryland Legislature Demographics House of Delegates The House of Delegates is comprised of 141 members with three in each Senate District. Administration 91 Democrats, 50 Republicans 98 Males, 43 Females 97 Caucasians, 36 African-Americans, 8 Asians 69 are native Marylanders Governor Larry Hogan Lt. Governor Boyd Rutherford 2

3 Presiding Officers Senate Standing Committees Budget & Taxation Education, Health, & Environmental Affairs Finance Judicial Proceedings Senate President Thomas V. Mike Miller Jr. Speaker of the House Michael E. Busch House Standing Committees Appropriations Economic Matters Environment & Transportation Health & Government Operations Judiciary Ways & Means 436 th Session - Dates of Interest January 13 th the day session convened January 20 th Final date for introduction of budget January 26 th - Bill request guarantee date February 3 rd State of the State Address February 5 th Senate Bill Introduction Date February 12 th - House Bill Introduction Date February 18 th MPhA Legislative Day in Annapolis February 26 th 45 th Day Halfway Point March 21 st - Crossover Day April 4 th Budget bill passage deadline April 11 th Adjourn sine die 3

4 Bills must be passed by both chambers and signed by the Governor to become law. Bill Passage Process 436 th Session so far As of Monday, January 25th, there had been 307 bills submitted for consideration in the Senate and 227 in the House. Five vetoes from 2015 have had override votes with all five being overridden. A sixth will be considered on February 5 th in the Senate. Bills of Interest HB 6 - Criminal Law Improper Prescription of Controlled Dangerous Substance Resulting in Death Sponsor: Delegate Karen Young (D Frederick) Synopsis: Prohibiting an authorized provider from prescribing, administering, distributing, or dispensing a controlled dangerous substance to a person if such practice is not in conformity with specified provisions of law and the standards of the authorized provider's profession relating to controlled dangerous substances and the person's use or ingestion of the controlled dangerous substance is a contributing cause of the person's death; establishing penalties of up to 20 years in prison or a fine of up to $100,000 or both; etc. Hearings: January 19 th, 1pm in Judiciary MPhA Position: Monitor and issue letter of concern regarding the broadness of this legislation. 4

5 HB 24 - Public Health - Overdose Response Program - Educational Training Program Requirement Sponsor: Delegate Kathy Szeliga (R-Baltimore & Harford) Synopsis: Requiring educational training for an Overdose Response Program overseen by the Department of Health and Mental Hygiene to include training in the requirement to immediately contact medical services after the administration of naloxone by a certificate holder instead of training in the importance of contacting emergency medical services. Hearings: February 2 nd, 1pm in Health & Government Operations MPhA Position: Monitor HB 56, SB 63- Investigational Drugs, Biological Products, and Devices - Right to Try Act Sponsor: Delegate Karen Young (D-Frederick), Senator Bryan Simonaire (R-Anne Arundel) Synopsis: Authorizing a manufacturer of an investigational drug, biological product, or device to make available the investigational drug, biological product, or device to eligible patients; specifying the manner in which a specified drug, product, or device may be provided to eligible patients; prohibiting a health occupations board from taking specified action against a health care provider's license on a specified basis; establishing that the Act does not create a specified cause of action; etc. Hearings: January 28th, 1pm in Health & Government Operations January 28 th, 1pm in Finance MPhA Position: Monitor HB 117 -State Board of Pharmacy - Licensure Requirements for Pharmacists - Proof of Proficiency in English Sponsor: Delegate Erek Barron (D-Prince George s) Synopsis: Providing that, for applicants for a license to practice pharmacy, graduation from specified schools is acceptable proof of proficiency in the oral communication of the English language. Hearings: January 28 th, 1pm in Health & Government Operations MPhA Position: Support requested by UMB Helpful Information 5

6 Online Sources of Information mgaleg.maryland.gov Maryland General Assembly Centermaryland.org Marylandreporter.com Annapolis News Clippings Need assistance? our Team (Steve) (Ashley) (Sherrie) Washingtonpost.com Baltimoresun.com Capitalgazette.com Papers with State House Reporters on staff Call our Annapolis Office Objectives CHANGING PHARMACY: THE MARYLAND LEGISLATIVE EFFORT IN 2016 Chai Wang, PharmD, BCPS, AE-C Discuss legislative climate in Annapolis Identify pharmacy-related bills introduced for the 2016 General session. Explain the role of the Maryland Pharmacy Coalition (MPC). Identify three different methods where a participate may support legislative efforts in Maryland. 6

7 Maryland Pharmacy Coalition (MPC) Maryland Chapter American Society of Consultant Pharmacists Maryland Pharmaceutical Society Maryland Pharmacists Association Maryland Society of Health System Pharmacy University of Maryland Baltimore School of Pharmacy Student Government Association University of Maryland Eastern Shore School of Pharmacy Student Government Association Notre Dame of Maryland University School of Pharmacy Student Government Association Why MPC? Unified voice for pharmacy Demonstrates that diverse pharmacy groups can and do come to consensus on important pharmacy issues Opportunity for different organizations to understand impact on various areas of practice. MPC Advocacy Victories Drug Therapy Management Sunset provision repeal Removal of protocol approval requirements Ability to initiate therapy Sterile Compounding Input Vaccination Authority Expansion How does MPC do its work? Input from stakeholders Bill identification Individual organizational vote Unanimous decision Lack of consensus 7

8 MPC Timeline Session Began: January 13 th MPC bill selection meeting: February 3 rd MPC statement development meeting: February 10 th Printing deadline: February 15 th Legislative Day: February 18 th What if I disagree with a stance MPC plans to take? Get involved Submit your input and feedback to your state association What if I want MPC to take a stance on a bill? Same as above plus Consider bringing it up with your individual representatives Legislative Day 2016 Date: February 18, 2016 Location: Francis Scott Key Auditorium, St John s College Event Morning briefing: 7:30 A.M. New this year: Improvements to the webapp with a dedicated domain Development of small group action teams to increase exposure before and after the General Assembly Additional preparatory workshops/forums Advocacy Activities Invite your legislator to your work Provide consultative advice on medical issues (don t always come with an ask) Letter-writing campaigns Testifying in Annapolis Submitting written testimony Educating patients and physicians 8

9 Barriers to advocacy What are your barriers to getting involved with the advocacy effort? Perfect Your Elevator Speech YM&feature=player_embedded Team Focus on patient Memorable story Improved outcomes Clinical Cost What did you hear? Audience Participation Case Study #1 A physician colleague asks about a pharmacist scope of practice bill he heard about from his professional medical association. How do you describe the value of the bill? Practice your elevator speech! 9

10 Case Study #2 Case Study #3 You are precepting a student who has an interest in advocacy but is overwhelmed on how to start to get involved. How would you guide the student? You are meeting with your legislator to discuss current pharmacy bills. She notes that it doesn t really matter because she isn t a member of a healthcare committee. How do you respond? Group Discussion Advocacy Workshop: February 11th Highly interactive advocacy workshop 10